Abstract
Human beings possess a considerable reserve capacity that allows them to benefit from exposure to highly enriched environments. The hypothesis of environmental complexity states that those individuals involved in activities that require greater cognitive demands keep their cognitive abilities undamaged despite the passing of time. The aim of this review is to present an analysis of the results obtained from empirical research made between 1980 and 2014 in Europe and America, focusing on the impact that cognitive reserve has on older adults.
This review will demonstrate how environmental complexity and the importance of engaging in recreational activities influence individuals’ lives and their cognitive healthy aging. Bibliography was obtained systematically, through a defined search strategy of several data bases. Ninety one scientific articles were selected in agreement with the appropriateness they keep with the objective of the present research.
In regard to pharmacological treatment, there is little evidence that cholinesterase inhibitor drugs affect progression to dementia or improve cognitive performance of patients with MCI. Complementarily, mixed results have been reported from different research lines that use cognitive training. Besides, there is increasing evidence that consider the role of environment and lifestyle as protective factors for the development of Alzheimer’s disease from MCI. The review sheds some suggestions for future research related to the studied topics and for professional intervention in the area of gerontology.
Keywords: Activity theory, cognitive functioning, environmental complexity, leisure activities, professional intervention, work complexity.
Current Psychopharmacology
Title:Occupational Complexity and Leisure Activities in Cognitive Aging
Volume: 3
Author(s): Carolina Feldberg, Dorina Stefani and Ricardo Francisco Allegri
Affiliation:
Keywords: Activity theory, cognitive functioning, environmental complexity, leisure activities, professional intervention, work complexity.
Abstract: Human beings possess a considerable reserve capacity that allows them to benefit from exposure to highly enriched environments. The hypothesis of environmental complexity states that those individuals involved in activities that require greater cognitive demands keep their cognitive abilities undamaged despite the passing of time. The aim of this review is to present an analysis of the results obtained from empirical research made between 1980 and 2014 in Europe and America, focusing on the impact that cognitive reserve has on older adults.
This review will demonstrate how environmental complexity and the importance of engaging in recreational activities influence individuals’ lives and their cognitive healthy aging. Bibliography was obtained systematically, through a defined search strategy of several data bases. Ninety one scientific articles were selected in agreement with the appropriateness they keep with the objective of the present research.
In regard to pharmacological treatment, there is little evidence that cholinesterase inhibitor drugs affect progression to dementia or improve cognitive performance of patients with MCI. Complementarily, mixed results have been reported from different research lines that use cognitive training. Besides, there is increasing evidence that consider the role of environment and lifestyle as protective factors for the development of Alzheimer’s disease from MCI. The review sheds some suggestions for future research related to the studied topics and for professional intervention in the area of gerontology.
Export Options
About this article
Cite this article as:
Feldberg Carolina, Stefani Dorina and Allegri Francisco Ricardo, Occupational Complexity and Leisure Activities in Cognitive Aging, Current Psychopharmacology 2014; 3 (1) . https://dx.doi.org/10.2174/2211556003666140717183716
DOI https://dx.doi.org/10.2174/2211556003666140717183716 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Design of Iodine-Lithium-α-Dextrin Liquid Crystal with Potent Antimicrobial and Anti-Inflammatory Properties
Current Pharmaceutical Design Mesenchymal Stem Cells: Potential in Treatment of Neurodegenerative Diseases
Current Stem Cell Research & Therapy Disruption of Calcium Homeostasis in the Pathogenesis of Alzheimers Disease and Other Conformational Diseases
Current Alzheimer Research Dehydroepiandrosterone (DHEA): A Steroid with Multiple Effects. Is there Any Possible Option in the Treatment of Critical illness?
Current Medicinal Chemistry Drug Transport Across the Blood-Brain Barrier and the Impact of Breast Cancer Resistance Protein (ABCG2)
Current Topics in Medicinal Chemistry A Randomized, Double-Blind, Placebo-Controlled Trial of Two Doses of Ginkgo Biloba Extract in Dementia of the Alzheimers Type
Current Alzheimer Research An fMRI Stroop Task Study of Prefrontal Cortical Function in Normal Aging, Mild Cognitive Impairment, and Alzheimers Disease
Current Alzheimer Research Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy
Current Alzheimer Research Diagnostic and Therapeutic Uses of Nanomaterials in the Brain
Current Medicinal Chemistry Neuroinflammation as a Common Mechanism Associated with the Modifiable Risk Factors for Alzheimer’s and Parkinson’s Diseases
Current Aging Science Therapeutic Agents for Alzheimers Disease
Current Medicinal Chemistry - Central Nervous System Agents Viral Inhibition of Tumour Necrosis Factor-α (TNFα) and TNF-Receptor Induced Apoptosis and Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Platelet GPIIb/IIIa Receptor Antagonists in Human Ischemic Brain Disease
Current Vascular Pharmacology Synthesis, Characterization and Physico-chemical Properties of New 2-(4- Arylpiperazine-1-yl)-1-(3-methylbenzofuran-2-yl)ethanoles as Potential Antihypertensive Agents
Current Organic Chemistry The Intracellular Domain of Amyloid Precursor Protein is a Potential Therapeutic Target in Alzheimer’s Disease
Current Drug Discovery Technologies Laminin and its Related Peptides for the Treatment of Alzheimers Disease
Current Medicinal Chemistry - Central Nervous System Agents Non Invasive Indexes for the Assessment of Patients with Non-alcoholic Fatty Liver Disease
Current Pharmaceutical Design A Molecular Bridge: Connecting Type 2 Diabetes and Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets NMDA Receptors are not Alone: Dynamic Regulation of NMDA Receptor Structure and Function by Neuregulins and Transient Cholesterol-Rich Membrane Domains Leads to Disease-Specific Nuances of Glutamate- Signalling
Current Topics in Medicinal Chemistry Ischemic and Oxidative Damage to the Hypothalamus May Be Responsible for Heat Stroke
Current Neuropharmacology